Daniel William Cramer, Sc.D., M.D.
This page shows the publications co-authored by Daniel Cramer and Naoko Sasamoto.
Racial/ethnic differences in average CA125 and CA15.3 values and its correlates among postmenopausal women in the USA. Cancer Causes Control. 2021 Mar; 32(3):299-309.
Common Analgesic Use for Menstrual Pain and Ovarian Cancer Risk. Cancer Prev Res (Phila). 2021 08; 14(8):795-802.
Epidemiologic and biologic correlates of serum HE4 and CA125 in women from the National Health and Nutritional Survey (NHANES). Gynecol Oncol. 2021 04; 161(1):282-290.
Peripheral Blood Leukocyte Telomere Length and Endometriosis. Reprod Sci. 2020 10; 27(10):1951-1959.
Development and validation of circulating CA125 prediction models in postmenopausal women. J Ovarian Res. 2019 Nov 26; 12(1):116.
Predicting Circulating CA125 Levels among Healthy Premenopausal Women. Cancer Epidemiol Biomarkers Prev. 2019 06; 28(6):1076-1085.
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma. Virchows Arch. 2022 Apr; 480(4):855-871.
Intrauterine device use and risk of ovarian cancer: Results from the New England Case-Control study and Nurses' Health Studies. Int J Cancer. 2021 07 01; 149(1):75-83.
Association Between Breastfeeding and Ovarian Cancer Risk. JAMA Oncol. 2020 06 01; 6(6):e200421.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.